{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:02:37Z","timestamp":1777982557255,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2022-19-93"],"award-info":[{"award-number":["320.6750.2022-19-93"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Science and Technology Innovation Medical Development Foundation","award":["KC2021-JX-0186-73"],"award-info":[{"award-number":["KC2021-JX-0186-73"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-025-04295-7","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:19:46Z","timestamp":1773746386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal analysis of peripheral blood immune status and prognosis dynamic prediction for advanced colon cancer with first-line chemotherapy"],"prefix":"10.1007","volume":"75","author":[{"given":"Fan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Guo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"issue":"3","key":"4295_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"4295_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D (2021) Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA 325(7):669\u2013685. https:\/\/doi.org\/10.1001\/jama.2021.0106","journal-title":"JAMA"},{"key":"4295_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3444360","volume":"2022","author":"A Liu","year":"2022","unstructured":"Liu A, Xia Y, Li W et al (2022) The predictive value of changes in the absolute counts of peripheral lymphocyte subsets for progression and prognosis in breast cancer patients. Contrast Media Mol Imaging 2022:3444360. https:\/\/doi.org\/10.1155\/2022\/3444360","journal-title":"Contrast Media Mol Imaging"},{"key":"4295_CR4","doi-asserted-by":"publisher","first-page":"8109","DOI":"10.2147\/cmar.S334094","volume":"13","author":"DS Shen","year":"2021","unstructured":"Shen DS, Yan C, Liang Y, Chen KH, Zhu XD (2021) Prognostic significance of circulating lymphocyte subsets before treatment in patients with nasopharyngeal carcinoma. Cancer Manag Res 13:8109\u20138120. https:\/\/doi.org\/10.2147\/cmar.S334094","journal-title":"Cancer Manag Res"},{"key":"4295_CR5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.cca.2014.10.012","volume":"439","author":"SZ Yang","year":"2015","unstructured":"Yang SZ, Ji WH, Mao WM, Ling ZQ (2015) Elevated levels of preoperative circulating CD44\u207a lymphocytes and neutrophils predict poor survival for non-small cell lung cancer patients. Clin Chim Acta 439:172\u2013177. https:\/\/doi.org\/10.1016\/j.cca.2014.10.012","journal-title":"Clin Chim Acta"},{"issue":"6","key":"4295_CR6","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00262-019-02343-7","volume":"68","author":"D Krijgsman","year":"2019","unstructured":"Krijgsman D, de Vries NL, Skovbo A et al (2019) Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile. Cancer Immunol Immunother 68(6):1011\u20131024. https:\/\/doi.org\/10.1007\/s00262-019-02343-7","journal-title":"Cancer Immunol Immunother"},{"issue":"12","key":"4295_CR7","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1002\/mds.28730","volume":"36","author":"X Ren","year":"2021","unstructured":"Ren X, Lin J, Stebbins GT, Goetz CG, Luo S (2021) Prognostic modeling of Parkinson\u2019s disease progression using early longitudinal patterns of change. Mov Disord 36(12):2853\u20132861. https:\/\/doi.org\/10.1002\/mds.28730","journal-title":"Mov Disord"},{"issue":"10","key":"4295_CR8","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00262-020-02590-z","volume":"69","author":"D Krijgsman","year":"2020","unstructured":"Krijgsman D, De Vries NL, Andersen MN et al (2020) The effects of tumor resection and adjuvant therapy on the peripheral blood immune cell profile in patients with colon carcinoma. Cancer Immunol Immunother 69(10):2009\u20132020. https:\/\/doi.org\/10.1007\/s00262-020-02590-z","journal-title":"Cancer Immunol Immunother"},{"issue":"11","key":"4295_CR9","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3748\/wjg.v11.i11.1639","volume":"11","author":"NI Nikiteas","year":"2005","unstructured":"Nikiteas NI, Tzanakis N, Gazouli M et al (2005) Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol 11(11):1639\u20131643. https:\/\/doi.org\/10.3748\/wjg.v11.i11.1639","journal-title":"World J Gastroenterol"},{"key":"4295_CR10","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.amsu.2021.01.013","volume":"62","author":"F Hidayat","year":"2021","unstructured":"Hidayat F, Labeda I, Sampetoding S et al (2021) Correlation of interleukin-6 and C-reactive protein levels in plasma with the stage and differentiation of colorectal cancer: a cross-sectional study in East Indonesia. Ann Med Surg (Lond) 62:334\u2013340. https:\/\/doi.org\/10.1016\/j.amsu.2021.01.013","journal-title":"Ann Med Surg (Lond)"},{"issue":"46","key":"4295_CR11","doi-asserted-by":"publisher","first-page":"75013","DOI":"10.18632\/oncotarget.12601","volume":"7","author":"M Thomsen","year":"2016","unstructured":"Thomsen M, Kersten C, Sorbye H et al (2016) Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer. Oncotarget 7(46):75013\u201375022. https:\/\/doi.org\/10.18632\/oncotarget.12601","journal-title":"Oncotarget"},{"issue":"1","key":"4295_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2217\/bmm.15.110","volume":"10","author":"C Chang","year":"2016","unstructured":"Chang C, Chiang AJ, Chen WA, Chang HW, Chen J (2016) A joint model based on longitudinal CA125 in ovarian cancer to predict recurrence. Biomark Med 10(1):53\u201361. https:\/\/doi.org\/10.2217\/bmm.15.110","journal-title":"Biomark Med"},{"issue":"1","key":"4295_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/ije\/dyu262","volume":"44","author":"\u00d6 Asar","year":"2015","unstructured":"Asar \u00d6, Ritchie J, Kalra PA, Diggle PJ (2015) Joint modelling of repeated measurement and time-to-event data: an introductory tutorial. Int J Epidemiol 44(1):334\u2013344. https:\/\/doi.org\/10.1093\/ije\/dyu262","journal-title":"Int J Epidemiol"},{"issue":"12","key":"4295_CR14","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1177\/09622802231206477","volume":"32","author":"A Devaux","year":"2023","unstructured":"Devaux A, Helmer C, Genuer R, Proust-Lima C (2023) Random survival forests with multivariate longitudinal endogenous covariates. Stat Methods Med Res 32(12):2331\u20132346. https:\/\/doi.org\/10.1177\/09622802231206477","journal-title":"Stat Methods Med Res"},{"issue":"7","key":"4295_CR15","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1158\/2326-6066.Cir-15-0298","volume":"4","author":"K Tada","year":"2016","unstructured":"Tada K, Kitano S, Shoji H et al (2016) Pretreatment immune status correlates with progression-free survival in chemotherapy-treated metastatic colorectal cancer patients. Cancer Immunol Res 4(7):592\u2013599. https:\/\/doi.org\/10.1158\/2326-6066.Cir-15-0298","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"4295_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1089\/cbr.1996.11.355","volume":"11","author":"AM Berghella","year":"1996","unstructured":"Berghella AM, Pellegrini P, Del Beato T, Maccarone D, Adorno D, Casciani CU (1996) Prognostic significance of immunological evaluation in colorectal cancer. Cancer Biother Radiopharm 11(6):355\u2013361. https:\/\/doi.org\/10.1089\/cbr.1996.11.355","journal-title":"Cancer Biother Radiopharm"},{"key":"4295_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.743448","volume":"12","author":"YT Chen","year":"2021","unstructured":"Chen YT, Hsu HC, Lee YS et al (2021) Longitudinal High-Throughput Sequencing of the T-Cell Receptor Repertoire Reveals Dynamic Change and Prognostic Significance of Peripheral Blood TCR Diversity in Metastatic Colorectal Cancer During Chemotherapy. Front Immunol 12:743448. https:\/\/doi.org\/10.3389\/fimmu.2021.743448","journal-title":"Front Immunol"},{"issue":"5","key":"4295_CR18","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.7314\/apjcp.2012.13.5.2219","volume":"13","author":"QM Yu","year":"2012","unstructured":"Yu QM, Yu CD, Ling ZQ (2012) Elevated circulating CD19+ lymphocytes predict survival advantage in patients with gastric cancer. Asian Pac J Cancer Prev 13(5):2219\u20132224. https:\/\/doi.org\/10.7314\/apjcp.2012.13.5.2219","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"4295_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1182\/blood.v98.1.23","volume":"98","author":"NE Kay","year":"2001","unstructured":"Kay NE, Leong TL, Bone N et al (2001) Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patients. Blood 98(1):23\u201328. https:\/\/doi.org\/10.1182\/blood.v98.1.23","journal-title":"Blood"},{"issue":"1","key":"4295_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00262-019-02449-y","volume":"69","author":"J Waidhauser","year":"2020","unstructured":"Waidhauser J, Schuh A, Trepel M, Schm\u00e4lter AK, Rank A (2020) Chemotherapy markedly reduces B cells but not T cells and NK cells in patients with cancer. Cancer Immunol Immunother 69(1):147\u2013157. https:\/\/doi.org\/10.1007\/s00262-019-02449-y","journal-title":"Cancer Immunol Immunother"},{"issue":"9","key":"4295_CR21","first-page":"1215","volume":"36","author":"SJ Li","year":"2016","unstructured":"Li SJ, Wu YX, Chen HL, Liu ML, Wu AB, Yang ZX (2016) [Correlation of CD4(+)CD29(+) regulatory T cells with recurrence and survival time in patients with non-small cell lung cancer]. Nan Fang Yi Ke Da Xue Xue Bao 36(9):1215\u20131220","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"4","key":"4295_CR22","first-page":"362","volume":"25","author":"G Xiao","year":"2003","unstructured":"Xiao G, Zhao G, Xu XD, Song JH, Huang MX, Wei JM (2003) [Alternation and significance of CD4(+)CD45RA(+) and CD4(+)CD45RO(+) T cells in peripheral blood of colorectal cancer patients]. Zhonghua Zhong Liu Za Zhi 25(4):362\u2013364","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"4295_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092134","author":"S Thongchot","year":"2021","unstructured":"Thongchot S, Vidoni C, Ferraresi A et al (2021) Cancer-associated fibroblast-derived IL-6 determines unfavorable prognosis in cholangiocarcinoma by affecting autophagy-associated chemoresponse. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13092134","journal-title":"Cancers (Basel)"},{"key":"4295_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021723","author":"C Vidoni","year":"2023","unstructured":"Vidoni C, Ferraresi A, Vallino L et al (2023) Glycolysis inhibition of autophagy drives malignancy in ovarian cancer: exacerbation by IL-6 and attenuation by resveratrol. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24021723","journal-title":"Int J Mol Sci"},{"key":"4295_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.lungcan.2019.03.014","volume":"131","author":"SJ Rice","year":"2019","unstructured":"Rice SJ, Liu X, Zhang J, Jia B, Zheng H, Belani CP (2019) Advanced NSCLC patients with high IL-6 levels have altered peripheral T cell population and signaling. Lung Cancer 131:58\u201361. https:\/\/doi.org\/10.1016\/j.lungcan.2019.03.014","journal-title":"Lung Cancer"},{"issue":"6","key":"4295_CR26","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1023\/b:ddas.0000034556.48527.6e","volume":"49","author":"C Miki","year":"2004","unstructured":"Miki C, Konishi N, Ojima E, Hatada T, Inoue Y, Kusunoki M (2004) C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma. Dig Dis Sci 49(6):970\u2013976. https:\/\/doi.org\/10.1023\/b:ddas.0000034556.48527.6e","journal-title":"Dig Dis Sci"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04295-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-025-04295-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04295-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:03:21Z","timestamp":1773792201000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-025-04295-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["4295"],"URL":"https:\/\/doi.org\/10.1007\/s00262-025-04295-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5382518\/v1","asserted-by":"object"}]},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"3 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study (NO.20240831041912189) was ratified by the ethic institutional review board of Shanghai Jiao Tong university medicine school affiliated General hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"108"}}